Oligonucleotide therapeutics have attracted much attention recently. They represent an up-and-coming class of therapeutic options that can lead to major advances in the treatment or cure of diseases, holding great potential for further development in human medicine.
Rna Oligo Purification Page In this Teach me in 10 we are joined by Chris Rosenau, product manager of nucleic acid therapeutics at Thermo Fisher Scientific. He covers the basics of oligonucleotide therapeutics, their trends and challenges, considerations for phosphoramdites in oligonucleotide synthesis, and resources from Thermo Fisher Scientific that are available to you in oligonucleotide therapeutic development. Further Resources: